Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.02.2020 | Case report

Ibrutinib/rituximab

Hepatitis B virus infection reactivation leading to liver failure: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Malek A, et al. Hepatitis b virus reactivation in patients with hematologic malignancies after anticancer therapy which included ibrutinib. Open Forum Infectious Diseases 6 (Suppl. 2): S156-S157 (plus poster) abstr. 288, Oct 2019. Available from: URL: http://doi.org/10.1093/ofid/ofz360.363 [abstract]CrossRef Malek A, et al. Hepatitis b virus reactivation in patients with hematologic malignancies after anticancer therapy which included ibrutinib. Open Forum Infectious Diseases 6 (Suppl. 2): S156-S157 (plus poster) abstr. 288, Oct 2019. Available from: URL: http://​doi.​org/​10.​1093/​ofid/​ofz360.​363 [abstract]CrossRef
Metadaten
Titel
Ibrutinib/rituximab
Hepatitis B virus infection reactivation leading to liver failure: case report
Publikationsdatum
01.02.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-74979-1

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Prednisone

Case report

Dapsone